Experiment: 2L21

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	5% D2O, 20 mM sodium acetate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
2	2D 1H-13C HSQC	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
3	3D HNCO	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
4	3D HNCA	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
5	3D HNCACB	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
6	3D C(CO)NH	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
7	3D CBCA(CO)NH	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
8	3D HN(CO)CA	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
9	3D H(CCO)NH	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
10	3D HCCH-TOCSY	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
11	3D 1H-15N NOESY	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
12	3D 1H-13C NOESY	5% D2O, 20 mM sodium phosphate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 13C; U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298
13	2D 1H-15N HSQC	5% D2O, 20 mM sodium acetate, 0.1 mM EDTA, 100 uM sodium azide, 0.5-1 mM [U-98% 15N] IGF2R	95% H2O/5% D2O	0	5.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	VNMRS	600
2	Varian	INOVA	600

NMR Refinement
Method	Details	Software
simulated annealing, simulated annealing	ARIA1.2 protocol. Cool_1 and cool_2 steps increased to 40K and cool_2, ARIA1.2 water refinement modified with RECOORD water refinement paramaters	VnmrJ

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	Some backbone datasets acquired using ASCOM with a reduced number of points in the nitrogen dimension

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VnmrJ		Varian
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	structure solution	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read
4	refinement	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read
5	geometry optimization	TALOS		Cornilescu, Delaglio and Bax
6	data analysis	TALOS		Cornilescu, Delaglio and Bax
7	structure solution	ARIA	1.2	Linge, O'Donoghue and Nilges
8	refinement	ARIA	1.2	Linge, O'Donoghue and Nilges
9	refinement	iCing	r765	Vuister, Doreleijers, Sousa da Silva
10	chemical shift assignment	CcpNmr Analysis	2.13	Vranken, Boucher, Stevens, Fogh, Pajon, Llinas, Ulrich, Markley, Ionides, Laue
11	data analysis	CcpNmr Analysis	2.13	Vranken, Boucher, Stevens, Fogh, Pajon, Llinas, Ulrich, Markley, Ionides, Laue

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.